InvivoGen

InvivoGen is a life-science research products company that develops and manufactures reagents, engineered biological systems, and related tools for academic, pharmaceutical, biotechnology, and other biomedical research. The company was founded in Toulouse, France, in 1977 and is based in San Diego, California. It conducts business internationally. The company is particularly associated with products used to study innate immunity and pathogen-recognition pathways. Its portfolio includes toll-like receptor products, including receptor ligands and engineered mammalian cell lines, as well as reagents connected with broader pattern-recognition-receptor research. These tools are used to investigate how cells detect microbial or danger-associated signals and how those signals influence inflammatory and immune responses. InvivoGen also supplies selection antibiotics and products for detecting and eliminating mycoplasma contamination in cell cultures. Mycoplasma-control products address a practical problem in biomedical research: contamination can alter cell physiology, compromise experimental reproducibility, and invalidate results. The company’s portfolio therefore spans both specialized immunology reagents and routine infrastructure for maintaining reliable laboratory cultures. Its product categories extend across cell lines, inhibitors, vaccine adjuvants, cloning and expression systems, cell-culture reagents, pattern-recognition-receptor ligands, antibodies and ELISA-related products, proteins and peptides, and genes and promoters. InvivoGen additionally offers human and rodent open reading frames, with a collection numbering more than 1,000 entries according to the referenced company description. The company provides services for immunomodulatory compound screening and custom cloning, complementing its catalog business with project-specific support. InvivoGen’s origins included a focus on gene-therapy products. Over time, its activities expanded toward innate-immunity research, immunology, cancer research, RNA interference, cell culture, cloning, and gene-expression applications. This evolution positioned the company as a specialist supplier serving researchers who need defined biological stimuli, validated cell systems, genetic constructs, and contamination-control tools. The brand’s business model is centered on research-use products rather than consumer healthcare or clinical therapeutics. Its offerings are used in laboratory experiments, assay development, cell-based screening, molecular biology workflows, and studies of immune signaling. The company’s international customer base includes research institutions and organizations working across immunology, oncology, infectious disease, molecular biology, and biotechnology. The referenced Wikipedia article reports that approximately 99,500 academic papers cite InvivoGen products, indicating substantial adoption in the scientific literature, although that figure is time-sensitive and not independently dated in the supplied material.

InvivoGen was established in 1977 in Toulouse, France. The company’s early work focused on gene-therapy-related products, providing a foundation in molecular and cellular biology technologies. As its activities developed, the business broadened its scope beyond gene therapy to serve a wider range of laboratory research applications. A major part of InvivoGen’s later identity developed around innate immunity and the study of cellular responses to microbial and danger signals. The company became known for toll-like receptor-related products, including receptor ligands and engineered mammalian cell lines. These offerings allow researchers to stimulate or measure defined immune-signaling pathways in controlled experimental systems. The portfolio also expanded into other pattern-recognition-receptor research, supporting investigations of how cells sense pathogens and initiate inflammatory responses. Alongside its immunology products, InvivoGen built a substantial set of tools for routine cell and molecular biology. Its catalog includes selection antibiotics, cloning and expression products, genes and promoters, proteins and peptides, antibodies, ELISA-related products, and cell-culture reagents. It also developed products for detecting and eliminating mycoplasma contamination. This combination of specialized immune-research tools and laboratory-maintenance products enabled the company to serve both focused pathway studies and broader research workflows. The company’s research scope came to include immunology, cancer research, RNA interference, cell culture, cloning, and gene expression. It also added vaccine adjuvants and other products relevant to immune modulation. A collection of more than 1,000 human and rodent open reading frames further extended its molecular-biology offering. In addition to catalog products, InvivoGen provides immunomodulatory compound screening and custom cloning services for projects requiring tailored experimental support. InvivoGen is based in San Diego, California, and operates internationally. Its products are used by academic and other biomedical researchers in laboratory studies involving innate immunity, receptor signaling, molecular biology, cell-based assays, and contamination control. The company’s continuing identity is that of a specialized life-science supplier rather than a consumer-facing healthcare brand or a developer of marketed therapeutic medicines.

1. 1977Company founded in Toulouse

   InvivoGen was founded in Toulouse, France, establishing the company that would later develop a broad portfolio of molecular biology and life-science research products.

   Source
2. Expansion from gene therapy into broader research tools

   After its early focus on gene-therapy products, InvivoGen expanded into innate immunity, immunology, cancer research, RNA interference, cell culture, cloning, and gene-expression applications.

   Source
3. Development of toll-like receptor and mycoplasma-control portfolios

   The company became associated with toll-like receptor ligands and engineered cell lines, while also developing products for mycoplasma detection and elimination in cell cultures.

   Source

A specialist supplier of research-use reagents and engineered biological tools for innate immunity, immunology, cell culture, molecular biology, and related biomedical research. InvivoGen combines immune-pathway products with practical laboratory tools such as selection antibiotics and mycoplasma-control systems.

• Toll-like receptor and pattern-recognition-receptor productsInnate-immunity research reagents

  InvivoGen supplies ligands and related reagents for toll-like receptors and other pattern-recognition receptors. These products are used to activate or investigate defined innate-immune signaling pathways, enabling research into pathogen sensing, inflammatory responses, receptor biology, and immunomodulatory mechanisms.

• Engineered mammalian cell linesCell-based research systems

  The company provides engineered mammalian cell lines designed for controlled investigation of receptor signaling and immune-response pathways. Such systems help researchers compare pathway activation, evaluate compounds, and perform cell-based assays under more defined experimental conditions than unmodified cells may provide.

• Mycoplasma detection and elimination productsCell-culture quality control

  InvivoGen offers products intended to identify and remove mycoplasma contamination from laboratory cell cultures. These tools support research quality and reproducibility by helping laboratories detect contamination and protect cultured cells used in molecular, immunological, and pharmaceutical research.

• Selection antibioticsMolecular biology reagents

  Selection antibiotics are used to maintain genetically modified cells or organisms carrying compatible resistance markers. InvivoGen includes these products in its research portfolio for cloning, gene-expression, stable-cell-line development, and related laboratory workflows.

• Genes, promoters, and open reading framesGenetic research tools

  The portfolio includes genes and promoters, as well as a collection of more than 1,000 open reading frames of human and rodent origin according to the referenced description. These materials support cloning, expression studies, functional biology, and construction of research systems.

• Cloning and expression productsMolecular biology

  InvivoGen provides products used in cloning and gene-expression workflows. The category supports the construction, propagation, selection, and expression of genetic material in laboratory systems and complements the company’s cell-line and gene-resource offerings.

• Antibodies, ELISAs, proteins, and peptidesImmunology research reagents

  The company’s immunology portfolio includes antibodies and ELISA-related products, along with proteins and peptides. These reagents support detection, characterization, and functional studies of immune-related molecules and biological responses.

• Immunomodulatory compound screening and custom cloningResearch services

  In addition to catalog products, InvivoGen offers services for screening immunomodulatory compounds and for custom cloning. These services extend the brand’s role from reagent supplier to project-support provider for researchers with specialized assay or construct requirements.

1. InvivoGen